Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.

PHARMA

Quarterly rpt on consolidated results for the financial period ended 31 Dec 2018

PHARMANIAGA BERHAD

Financial Year End 31 Dec 2018
Quarter 4 Qtr
Quarterly report for the financial period ended 31 Dec 2018
The figures have not been audited

Attachments

Pharma Q4 2018.pdf
421.5 kB

  • Default Currency
  • Other Currency

Currency: Malaysian Ringgit (MYR)

SUMMARY OF KEY FINANCIAL INFORMATION
31 Dec 2018

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
31 Dec 2018
31 Dec 2017
31 Dec 2018
31 Dec 2017
$$'000
$$'000
$$'000
$$'000
1 Revenue
596,644
613,196
2,384,956
2,323,960
2 Profit/(loss) before tax
11,940
19,866
70,220
73,064
3 Profit/(loss) for the period
4,570
22,088
43,230
55,087
4 Profit/(loss) attributable to ordinary equity holders of the parent
4,437
21,700
42,468
53,823
5 Basic earnings/(loss) per share (Subunit)
1.71
8.36
16.33
20.74
6 Proposed/Declared dividend per share (Subunit)
2.00
6.00
16.00
19.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
1.9600
2.0300

Definition of Subunit:

In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:

Country Base Unit Subunit
Malaysia Ringgit Sen
United States Dollar Cent
United Kingdom Pound Pence




Announcement Info

Company Name PHARMANIAGA BERHAD
Stock Name PHARMA
Date Announced 21 Feb 2019
Category Financial Results
Reference Number FRA-20022019-00003